COVID-19 Outcome and Tobacco Product Use: Case-Control and Retrospective Cohort Studies Using Nationwide Samples
CONCLUSION: Current CC smokers and current users of any tobacco product showed reduced risk of SARS-CoV-2 infection and COVID-19-related hospitalization. It remains uncertain whether these relationships are causal.PMID:38529574 | PMC:PMC10963176 | DOI:10.3346/jkms.2024.39.e103
Source: Journal of Korean Medical Science - Category: Biomedical Science Authors: Seo Young Kang Ye-Jee Kim Hong-Jun Cho Source Type: research
More News: Biomedical Science | Coronavirus | COVID-19 | Health Insurance | Insurance | Respiratory Medicine | SARS | Science | Smokers | Study